Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$2.1 - $3.36 $2.1 Million - $3.36 Million
1,001,000 Added 23.75%
5,215,740 $12 Million
Q4 2022

Feb 06, 2023

BUY
$2.05 - $3.47 $1.7 Million - $2.88 Million
830,000 Added 24.52%
4,214,740 $10.6 Million
Q3 2022

Nov 14, 2022

BUY
$0.63 - $5.47 $335,160 - $2.91 Million
532,000 Added 18.65%
3,384,740 $9.82 Million
Q2 2022

Aug 15, 2022

BUY
$4.27 - $8.26 $1.27 Million - $2.47 Million
298,500 Added 11.69%
2,852,740 $12.9 Million
Q1 2022

May 16, 2022

BUY
$7.07 - $11.62 $6.96 Million - $11.4 Million
984,200 Added 62.69%
2,554,240 $20.5 Million
Q4 2021

Feb 14, 2022

BUY
$10.49 - $14.28 $4.27 Million - $5.81 Million
406,848 Added 34.98%
1,570,040 $18.3 Million
Q3 2021

Nov 12, 2021

BUY
$9.94 - $12.77 $11.6 Million - $14.9 Million
1,163,192 New
1,163,192 $14.4 Million

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Tikvah Management LLC Portfolio

Follow Tikvah Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tikvah Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tikvah Management LLC with notifications on news.